Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CareDx, Inc. (CDNA : NSDQ)
 
 • Company Description   
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Number of Employees: 650

 
 • Price / Volume Information   
Yesterday's Closing Price: $19.23 Daily Weekly Monthly
20 Day Moving Average: 973,570 shares
Shares Outstanding: 55.68 (millions)
Market Capitalization: $1,070.74 (millions)
Beta: 2.18
52 Week High: $34.84
52 Week Low: $14.09
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 13.18% 8.39%
12 Week 11.28% -8.53%
Year To Date -10.18% -14.42%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
8000 Marina Boulevard 4th Floor
-
Brisbane,CA 94005
USA		 ph: 415-287-2300
fax: 415-287-2450		 investor@caredx.com http://www.caredx.com
 
 • General Corporate Information   
Officers
John W. Hanna - President and Chief Executive Officer
Abhishek Jain - Chief Financial Officer
George W. Bickerstaff - Director
Fred E. Cohen - Director
Christine M. Cournoyer - Director

Peer Information
CareDx, Inc. (CHCR)
CareDx, Inc. (ESRX)
CareDx, Inc. (MYDP)
CareDx, Inc. (COR)
CareDx, Inc. (GBCS)
CareDx, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 14167L103
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
Share - Related Items
Shares Outstanding: 55.68
Most Recent Split Date: (:1)
Beta: 2.18
Market Capitalization: $1,070.74 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.11 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.39 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/30/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 16.72
PEG Ratio: -
Price Ratios
Price/Book: 2.82
Price/Cash Flow: 14.14
Price / Sales: 3.09
EPS Growth
vs. Year Ago Period: 32.14%
vs. Previous Quarter: -112.58%
Sales Growth
vs. Year Ago Period: 17.54%
vs. Previous Quarter: -2.19%
ROE
03/31/25 - 21.16
12/31/24 - 21.87
09/30/24 - -53.70
ROA
03/31/25 - 14.25
12/31/24 - 13.59
09/30/24 - -30.42
Current Ratio
03/31/25 - 4.11
12/31/24 - 3.94
09/30/24 - 4.10
Quick Ratio
03/31/25 - 3.84
12/31/24 - 3.72
09/30/24 - 3.87
Operating Margin
03/31/25 - 19.79
12/31/24 - 19.20
09/30/24 - -45.30
Net Margin
03/31/25 - 19.79
12/31/24 - 18.65
09/30/24 - -45.90
Pre-Tax Margin
03/31/25 - 18.05
12/31/24 - 15.84
09/30/24 - -46.83
Book Value
03/31/25 - 6.81
12/31/24 - 7.06
09/30/24 - 5.18
Inventory Turnover
03/31/25 - 5.54
12/31/24 - 5.61
09/30/24 - 5.48
Debt-to-Equity
03/31/25 - 0.00
12/31/24 - 0.00
09/30/24 - 0.00
Debt-to-Capital
03/31/25 - 0.00
12/31/24 - 0.00
09/30/24 - 0.00
 

Powered by Zacks Investment Research ©